Skip to content
Back to Investors
B

Bynd

Venture Capital

Portfolio

2

companies

Investment by month

By category

  • BioTech£3.0M
  • AI/ML£1.2M

By location

  • London£4.2M

Portfolio companies

CC

Cori Clinical

AI workspace designed to reduce clinical trial protocol amendments and set-up costs.

N

Noxus

Noxus enables enterprises to build and deploy custom artificial intelligence workforces.


Recent investments

Seed
$4.0M

The round was led by Breega to support delivery capacity and team growth.

"Clinical trials are built through a series of interconnected decisions about how a study should be designed and run. Today, much of the knowledge and precedent behind those decisions is scattered across previous trials, siloed teams, internal systems and separate documents. Cori brings that intelligence together into a living blueprint, so teams can make better-informed decisions before avoidable problems become delays, so the science never waits on the process,"
— Jorn Jansen Schoonhoven, Investor
Pre-Seed
£1.2M

The pre-seed round was led by SFC Capital to support platform development and operational expansion.

"Noxus is addressing a crucial challenge for large enterprises: implementing AI in production to achieve meaningful productivity gains without the usual complexity or risks. As organizations worldwide explore how to build their AI workforce and capitalize on this next wave of innovation, Noxus takes a unique approach. They’ve developed a horizontal platform designed to democratize AI adoption for legacy companies, empowering them to compete and thrive in a rapidly evolving landscape. We’re proud to back João, Jorge, and their team as they enable organizations to seamlessly integrate AI into their operations and unlock its transformative potential."
— Vegard Medbo, COO